The Risperdal Disaster
As one of Janssen Pharmaceutical’s best selling drugs, Risperdal prescriptions are estimated to be filled 12 million times a year in the United States.
But the history behind this antipsychotic drug is one full of scandal, deception, and harm to the public.
Initially approved for sale in 1993, Risperdal is a second generation antipsychotic prescribed for psychological issues including schizophrenia, manic episodes in bipolar disorder, and for the treatment of irritability in children with autism spectrum disorders.
Risperdal is the brand name of the generic drug risperdone.
The manufacturer of Risperdal, Janssen Pharmaceuticals Inc., marketed it aggressively, often for unapproved or “off-label” uses.
Additionally, Janssen has been found guilty of providing illegal incentives to healthcare providers to prescribe this drug.
Given the lengthy history of unethical business practices revolving around Risperdal, it is no surprise that Risperdal has now been found to cause side effects users and physicians were not made aware of – side effects Janssen kept hidden.
Risperdal causes gynecomastia, a condition in which male breast tissue swells, often painfully, leading to the development of male breasts. This can cause physical and psychological trauma to the individual, and sometimes has to be surgically corrected.
The occurence of Risperdal gynecomastia is so high that it is suspicious that Janssen Pharmaceuticals did not seem to notice this severe Risperdal side effect in their pre-market clinical testing.
Could Janssen have possibly missed Risperdal gynecomastia? Or did they know very well it would happen, but hid it to sell more prescriptions?
New Study on Risperdal Gynecomastia
Recently, on August 6, 2014, researchers from the University of Columbia published a study on Risperdal gynecomastia in the Journal of Clinical Psychopharmacology.
Researchers in the study reviewed the medical records of over 82,000 American men between the ages of 45 and 80. They compared data between many different types of medications, and found that Risperdal was more likely to cause gynecomastia than other antipsychotic drugs.
Of 174 men on Risperdal, 27 of them developed Risperdal gynecomastia within 2 months of taking the medication. The researchers hypothesized that some users could develop Risperdal gynecomastia within as little as 2 weeks of ingesting the drug.
That means over 15% of men aged 45-80 developed Risperdal gynecomastia within two months of taking the medication.
How does this compare to another antipsychotic?
Seroquel had another surprisingly high incidence of 10% gynecomastia cases, which is still significantly lower than the Risperdal gynecomastia risk.
The Risperdal Lawsuit
Janssen Pharmaceuticals has been to court over Risperdal many times in the past, and we anticipate they will continue to be sued over the drug, and for good cause.
The Risperdal settlement in 2013 resulted in a landmark $2.2 billion fine against the company for the unlawful marketing of the drug.
Many Risperdal gynecomastia victims have already successfully sued Janssen for medical bills, pain and suffering, and other damages.
The Risperdal lawsuit is gaining momentum as the science continues to clarify the hidden risks of the drug.
If you have been affected by Risperdal gynecomastia, we strongly recommend that you seek legal counsel to get advice on your legal rights.
We can help. At Attorneys Band Gates & Dramis we are dedicated to fighting for the rights of the wronged, and helping you get the Risperdal settlement you deserve. Our Risperdal attorneys will fight tirelessly for your rights, so you can focus on recovery.
Please call us today for a free consultation. We are so confident we will win our clients a fair Risperdal settlement, that we do not charge anything until you are paid your Risperdal settlement.